Vital KSK HoldingsTSE:3151 -0.85%69 ROE % is 5.19% as of Mar. 2026, which is 2% above its 10-year median of 5.07. GuruFocus rates TSE:3151 with a GF Score™ of 69/100 and a GF Value™ of 円1,322.65 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Vital KSK Holdings ranks worse than 53.91% on this metric.
The historical rank and industry rank for Vital KSK Holdings's ROE % or its related term are showing as below:
TSE:3151'
s ROE % Range Over the Past 10 Years
Min: 1.18 Med: 5.07 Max: 6.94
Current: 6.75
During the past 13 years, Vital KSK Holdings's highest ROE % was 6.94%. The lowest was 1.18%. And the median was 5.07%.
TSE:3151's ROE % is ranked worse than 53.91% of 115
companies
in the Medical Distribution industry
Industry Median: 7.1
vs TSE:3151: 6.75
Vital KSK Holdings (TSE:3151) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Vital KSK Holdings ROE % Related Terms
Vital KSK Holdings ROE % Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Vital KSK Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Vital KSK Holdings (TSE:3151) has a ROE % of 5.19% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vital KSK Holdings and its competitors. This is near median its historical median of 5.07. Over the past decade, Vital KSK Holdings' ROE % has ranged from 1.18 to 6.94. According to the industry distribution chart, Vital KSK Holdings ranks #62 out of 115 companies in the Medical Distribution industry, placing it in the top 53.9%.
Is Vital KSK Holdings' ROE % too high?
Vital KSK Holdings' current ROE % of 5.19% is near median its 10-year median of 5.07. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 6.94. The Medical Distribution industry median ROE % is 7.10. Vital KSK Holdings' value of 5.19% is 26.9% below this industry median. Based on the distribution chart, Vital KSK Holdings ranks #62 out of 115 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' ROE % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #62 out of 115 companies for ROE %. This places Vital KSK Holdings in the lower half of its industry. The industry median ROE % is 7.10. Vital KSK Holdings' value of 5.19% is 26.9% below this benchmark. Historically, Vital KSK Holdings' own ROE % has ranged from 1.18 to 6.94 over the past decade. While the company's 10-year median is 5.07 vs. the industry median of 7.10, Vital KSK Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current ROE % of 5.19% is 26.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current ROE % is 5.19%, which is near median its own 10-year median of 5.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,322.65, compared to a current price of 円1,520.00 — trading 14.9% above its estimated fair value. The current ROE % is 5.19%, which is near median its 10-year median of 5.07 and 26.9% below the Medical Distribution industry median of 7.10. Vital KSK Holdings' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current ROE % is 5.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,520.00 is trading 14.9% above its estimated GF Value™ of 円1,322.65.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
ROE %: 5.19% (near median its 10-year median of 5.07)
GF Value™: 円1,322.65 vs. price of 円1,520.00 (14.9% above fair value)
Industry Position: 26.9% below the Medical Distribution median (#62 of 115)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
69GF Score
Get the complete analysis for TSE:3151
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
